ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies

  CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.

• The Strategic Case For RTSM in Phase 1 Trials

  Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.

• Why Prospective Real-World Studies Hold Promise For Research

  Clinical research has always been a cautious and time-consuming affair. Discover how prospective real-world studies are poised to transform the role of RWE in clinical research.

• Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent

  Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.

• The Strategic Role Of KOLs In Rare Disease Drug Development

  Engaging key Opinion Leaders (KOL) is crucial for accelerating rare disease research breakthroughs. However, identifying the right experts is challenging due to fragmented data and evolving expertise.

• Trends Shaping The Pharmaceutical Industry's Future

  Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.

• How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers

  Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.

• Revolutionizing Pediatric Clinical Trials With ePRO And eConsent

  Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.

• Achieving Clinical Operations Excellence

  Learn how Revvity Signals Software clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.

• Five Steps To Streamline Your Trial

  Explore the solution for adequately verifying and analyzing data from wearables, remote devices, and other novel data collection modalities.